Delivery Order SPE2DB22D2206-SPE2DB25FHF44
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Infuvite Adult Bulk Vial 100ML, a nutritional supplement product. This firm fixed-price delivery order, valued at $11,687.94, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $13,460.20 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product. The award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract falling under a larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,461.28 by the Defense Logistics Agency for Infuvite Adult Vial 10ML, a pharmaceutical product used in medical supply and healthcare delivery. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 22, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a $6,378.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. This non-set-aside, firm fixed-price contract is scheduled for completion by June 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Infuvite Pediatric Bulk Vial 50ml pharmaceutical product. This firm fixed-price delivery order, valued at $5,017.61, represents a non-set-aside competitive award with an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,793.37 for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This firm fixed-price delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHF44Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,031.97 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established position as a major pharmaceutical distributor and healthcare solutions provider with demonstrated capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 6/2/25 |